Role of histamine H4 receptor in allergic conjunctivitis in mice

被引:26
作者
Nakano, Yoshiyuki [1 ]
Takahashi, Yuji [1 ]
Ono, Rie [1 ]
Kurata, Yasunori [1 ]
Kagawa, Yoto [1 ]
Kamei, Chiaki [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med Pharmacol, Okayama 7008530, Japan
关键词
Allergic conjunctivitis; Histamine; JNJ7777120; H4; receptor; ICR mice; HUMAN-SKIN; PHARMACOLOGICAL CHARACTERIZATION; MOLECULAR-CLONING; MAST-CELLS; RESPONSES; PRURITUS; POTENT; ANTIHISTAMINES; INFLAMMATION; ANTAGONISTS;
D O I
10.1016/j.ejphar.2009.02.035
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We investigated the character of histamine H-1 receptor and H-4 receptor in allergic conjunctivitis. Histamine is the most important mediator in allergic conjunctivitis. We measured eye scratching behavior and allergic-like symptoms score, that is, hyperemia and edema in ICR mice, and examined which receptors intimately involved in allergic conjunctivitis. Histamine caused a dose-dependent eye scratching behavior and allergic-like symptoms. Histamine H-1 receptor antagonist (levocabastine) and H-4 receptor antagonist (JNJ7777120) inhibited eye scratching behavior and histamine H-1 receptor antagonist inhibited allergic-like symptoms induced by histamine. Additionally, combination of levocabastine and JNJ7777120 caused more potent inhibition in allergic conjunctivitis. On the other hand, both selective histamine H-1 receptor agonist (HTMT) and selective H-4 receptor agonist (4-methylhistamine) induced a dose-dependent eye scratching behavior and allergic-like symptoms. JNJ7777120 inhibited the effect of HTMT. However, levocabastine caused no inhibition on the response of 4-methylhistamine. H-4 receptor was closely related with allergic conjunctivitis. H-4 receptor antagonists may be effective in allergic conjunctivitis which showed no inhibition by histamine H-1 receptor antagonists. (c) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:71 / 75
页数:5
相关论文
共 32 条
[1]   NUMBER OF INFLAMMATORY CELLS IN NORMAL CONJUNCTIVA [J].
ALLANSMITH, MR ;
GREINER, JV ;
BAIRD, RS .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1978, 86 (02) :250-259
[2]   AUTO-INHIBITION OF BRAIN HISTAMINE-RELEASE MEDIATED BY A NOVEL CLASS (H-3) OF HISTAMINE-RECEPTOR [J].
ARRANG, JM ;
GARBARG, M ;
SCHWARTZ, JC .
NATURE, 1983, 302 (5911) :832-837
[3]   RECEPTORS MEDIATING SOME ACTIONS OF HISTAMINE [J].
ASH, ASF ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1966, 27 (02) :427-&
[4]   DEFINITION AND ANTAGONISM OF HISTAMINE H2-RECEPTORS [J].
BLACK, JW ;
PARSONS, EM ;
DURANT, CJ ;
DUNCAN, WAM ;
GANELLIN, CR .
NATURE, 1972, 236 (5347) :385-&
[5]  
Buckley RJ, 1998, CLIN EXP ALLERGY, V28, P39
[6]  
DAVIES MG, 1980, BRIT J CLIN PHARMACO, V9, P461
[7]   The histamine H4 receptor as a new therapeutic target for inflammation [J].
de Esch, IJP ;
Thurmond, RL ;
Jongejan, A ;
Leurs, R .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (09) :462-469
[8]   Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus [J].
Dunford, Paul J. ;
Williams, Kacy N. ;
Desai, Pragnya J. ;
Karlsson, Lars ;
McQueen, Daniel ;
Thurmond, Robin L. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) :176-183
[9]  
HAGERMARK O, 1979, ACTA DERM-VENEREOL, V59, P297
[10]   Effects of nonsteroidal anti-inflammatory drugs on experimental allergic conjunctivitis in guinea pigs [J].
Hashimoto, T ;
Igarashi, A ;
Hoshina, F ;
Yamada, M ;
Toyoda, Y ;
Notsu, Y ;
Kohno, S .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2003, 19 (06) :569-577